Wie produceert Gaviscon Adapted Formulation Mint 250 mg chewable tabl.?

Reckitt Benckiser (Healthcare) SA-NV (BE)

Tot welke ATC-klasse behoort Gaviscon Adapted Formulation Mint 250 mg chewable tabl.?

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.: ATC A02BX13 Alginic Acid. ATC is de WHO-classificatie van geneesmiddelen.

OTC

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.: Chewable tablet (Oral use)

Chewable tablet

INN: Sodium Alginate

Bijgewerkt: 2026-04-11

Verkrijgbaar in:

🇩🇪🇬🇧🇷🇴🇷🇺🇹🇷

Vorm

Chewable tablet

Dosering

—

Toedieningsweg

Oral use

Bewaring

—

Over dit product

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.